IBD - Crohn's & Colitis
Chronic Inflammatory Bowel Disease of the GI Tract

IBD is a chronic inflammatory disease of the GI tract with acute flare-ups alternating with periods of remission. The two major forms of the disease are Ulcerative Colitis and Crohn’s Disease. IBD can have a significant impact on the patients quality of life, and left untreated, IBD may lead to complications such as: surgery, hospitalization, severe infections, venous thromboembolism, colorectal cancer.

"Treat To Target" Strategy

1

Use Steroid-Sparing Strategy To Treat Symptoms

Decrease bleeding, frequency, urgency, pain etc.

2

Decrease Inflammation

Assessed by blood/stool biomarkers, endoscopic assessment (mucosal healing = bowel healing)

!

Aspirational Goal = Functional Remission

Having the patient get control of their life again, so they can get back to work, social life, travel, and family gatherings. Gastro of the Rockies has multiple advanced therapies available with varying mechanisms of action and modes of administration (oral, IV, subcutaneous) to target inflammation and treat patients with IBD.

IBD & IBS: Similarities & Differences

Inflammatory Bowel Disease (IBD) is the  Inflammation or destruction of the bowel wall,  leading to sores & narrowing of the intestines. It is a structural disease where physical damage causes symptoms. Doctors can see chronic inflammation or ulcers when they inspect the gut.

Irritable Bowel Syndrome (IBS) is a disorder of the gastrointestinal (GI) tract. It is a functional disease, which means that tests (such as a colonoscopy, stool or blood tests) won’t show any physical reason for symptoms. It’s possible to have both IBD and IBS.

Dr. Joshua Steinberg: Director of IBD

Joshua M. Steinberg, MD, is the Director of IBD with advanced IBD training from the University of Chicago. Dr. Steinberg takes a comprehensive approach in treating patients with Crohn’s and Ulcerative Colitis ranging from mild to severely complex disease. 

Joshua Steinberg